Boston Scientific

Boston Scientific is a global medical technology leader dedicated to transforming lives through innovative solutions that address unmet clinical needs. With a strong presence in neuromodulation, the company partners closely with clinicians and healthcare systems worldwide to advance therapies that improve outcomes and expand treatment possibilities for patients living with complex neurological conditions.
In Deep Brain Stimulation (DBS), Boston Scientific is committed to redefining precision, confidence, and personalization through Image Guided DBS. By integrating advanced imaging into the DBS workflow, Image Guided DBS provides physicians with greater anatomical insight and confidence throughout the therapy journey — from planning and lead placement to programming and long-term optimization. This approach supports more informed clinical decisions and helps tailor therapy to each patient’s unique anatomy and needs.
Boston Scientific’s DBS portfolio combines Image Guided DBS with advanced stimulation capabilities, intuitive programming, and MRI-conditional systems. Together, these technologies are designed to simplify clinical workflows, enable data-driven therapy optimization, and support consistent, high-quality care over time. For patients, this means a therapy experience built around precision, adaptability, and long-term confidence.
Innovation at Boston Scientific is grounded in collaboration. We work closely with physicians, researchers, and industry partners to translate scientific insight into practical, real-world solutions. Our continued investments in imaging-enabled workflows, digital health, remote programming, and next-generation neuromodulation reflect our belief that the future of DBS lies in smarter, more connected, and more personalized care ecosystems.
Beyond technology, Boston Scientific is driven by a deep commitment to ethical leadership, quality, and sustainability. We strive to operate responsibly, foster diversity and inclusion, and make a meaningful impact in the communities we serve. Through education, clinical evidence generation, and ongoing support, we aim to be a trusted partner throughout the entire patient journey.
At the 3rd DBS Expert Summit, Boston Scientific is proud to engage with the global neuromodulation community to share knowledge, explore emerging science, and collaborate on shaping the future of DBS therapy — advancing precision care through Image Guided DBS.